Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s stock price dropped 19.7% on Wednesday . The company traded as low as C$2.15 and last traded at C$2.16. Approximately 61,248 shares changed hands during mid-day trading, a decline of 57% from the average daily volume of 141,811 shares. The stock had previously closed at C$2.69.
Cardiol Therapeutics Trading Down 2.8 %
The stock’s 50 day moving average is C$2.76 and its two-hundred day moving average is C$2.83. The company has a market capitalization of C$171.90 million, a PE ratio of -5.59 and a beta of 0.70. The company has a quick ratio of 6.84, a current ratio of 2.39 and a debt-to-equity ratio of 1.07.
About Cardiol Therapeutics
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- Using the MarketBeat Stock Split Calculator
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What Are Dividend Achievers? An Introduction
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- How to Start Investing in Real Estate
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
